amoxicillin has been researched along with linezolid in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.44) | 18.2507 |
2000's | 15 (36.59) | 29.6817 |
2010's | 19 (46.34) | 24.3611 |
2020's | 6 (14.63) | 2.80 |
Authors | Studies |
---|---|
Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Licci, A; Okroj, M; Scalise, G; Silvestri, C | 1 |
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Entenza, JM; Leclercq, R; Moreillon, P; Wilson, WR | 1 |
Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
Brickner, SJ; Duignan, J; Finegan, S; Girard, D; Huband, MD; Le, PT; Maloney, M; Schafer, J; Stone, GG; Wade, SK; Zaniewski, RP | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Amaral, K; Dzink-Fox, J; Fischer, E; Goldovitz, J; Manni, K; Neckermann, G; Osborne, CS; Pecanka, R; Ryder, NS; Yu, D | 1 |
Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
Aubart, K; Duan, Y; Fang, Y; Hu, W; Ma, H; Shi, W; Yang, L; Zonis, R | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Hu, W; Lv, F; Shi, W; Xing, D; Yang, L; Yang, S; Yang, Y; Zhao, Z | 1 |
Biava, M; Cocozza, M; Consalvi, S; Poce, G | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
Erwin, ME; Jones, RN; Worth, S | 1 |
Albut, R; Figueira, M; Pelton, SI; Stalker, D | 1 |
Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, ML; Wimmer, M | 1 |
González-Lahoz, JM; Laguna, F; Moreno, V; Valencia, ME | 1 |
Berini-Aytés, L; Brescó-Salinas, M; Costa-Riu, N; Gay-Escoda, C | 1 |
Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
Cavazos-Rocha, N; de la Luz Salazar-Cavazos, M; Vera-Cabrera, L; Waksman-de-Torres, N; Welsh-Lozano, O | 1 |
Eden, A; Le Falher, G; Le Moing, V; Lesnik, A; Makinson, A; Reynes, J | 1 |
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
Buszewski, B; Jackowski, M; Szeliga, J; Szultka, M | 1 |
Buszewski, B; Jackowski, M; Krzeminski, R; Szeliga, J; Szultka, M | 1 |
Descourouez, JL; Jorgenson, MR; Rose, WE; Wergin, JE | 1 |
Boyanova, L; Evstatiev, I; Gergova, G; Mitov, I; Yaneva, P | 1 |
Abou-Aisha, K; Akram, FE; El-Azizi, M; El-Tayeb, T | 1 |
Ahuja, S; Benedetti, A; Cox, H; Fox, GJ; Koh, WJ; Menzies, D; Pasvol, G; Viiklepp, P | 1 |
Chudzik-Rząd, B; Malm, A; Paneth, A; Plech, T; Trotsko, N; Wujec, M | 1 |
Buszewski, B; Król-Górniak, A; Pauter, K; Pomastowski, P; Szultka-Młyńska, M; Szumski, M | 1 |
Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A | 1 |
Bock, M; Bruun, NE; Bundgaard, H; Christensen, JJ; Christiansen, U; Elming, H; Fosbøl, EL; Fuursted, K; Gill, S; Helweg-Larsen, J; Høfsten, D; Høiby, N; Ihlemann, N; Iversen, K; Kristensen, JH; Køber, L; Lemming, L; Lerche, CJ; Moser, C; Nielsen, HL; Pedersen, CT; Povlsen, JA; Pries-Heje, MM; Rosenvinge, FS; Schultz, M; Theut, AM; Tønder, N; van Hasselt, JGC; Wang, H | 1 |
Canut, A; Giacani, L; González-Beiras, C; González-Candelas, F; Greninger, AL; Lieberman, NAP; Mitjà, O; Mueller, J; Pérez-Mañá, C; Rodríguez-Gascón, A; Suñer, C; Tantalo, LC; Tapia, K; Ubals, M; Vall Mayans, M | 1 |
3 review(s) available for amoxicillin and linezolid
Article | Year |
---|---|
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
Topics: Animals; Antitubercular Agents; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis.
Topics: Adult; Amoxicillin; Antitubercular Agents; Clofazimine; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Linezolid; Logistic Models; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Oxazolidinones; Thioacetazone; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
38 other study(ies) available for amoxicillin and linezolid
Article | Year |
---|---|
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Positive Cocci; Hemolysis; Humans; Lipoproteins; Microbial Sensitivity Tests; Molecular Structure; Peptides | 2007 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
Topics: Acetamides; Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endocarditis, Bacterial; Enterococcus faecalis; Female; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rats; Rats, Wistar; Vancomycin Resistance | 2007 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
In vitro antibacterial activity of CE-156811, a novel analog derived from hygromycin A.
Topics: Acetamides; Anti-Bacterial Agents; Cinnamates; Dioxoles; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hygromycin B; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
Topics: Acetamides; Amidohydrolases; Animals; Anti-Infective Agents; Female; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Peptides; Pneumonia; Staphylococcus aureus; Streptococcus pneumoniae; Thigh | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Topics: Amidohydrolases; Anti-Bacterial Agents; Drug Design; Drug Resistance, Bacterial; Enzyme Inhibitors; Haemophilus influenzae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrrolidines | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Oligopeptides; Structure-Activity Relationship | 2014 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical
Topics: Acetamides; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Clavulanic Acids; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality Control; Roxithromycin; Ticarcillin | 1996 |
Efficacy of linezolid in experimental otitis media.
Topics: Acetamides; Amoxicillin; Animals; Anti-Bacterial Agents; Chinchilla; Disease Models, Animal; Drug Resistance, Microbial; Drug Resistance, Multiple; Haemophilus Infections; Haemophilus influenzae; Humans; Linezolid; Otitis Media; Oxazoles; Oxazolidinones; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Helicobacter pylori; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillins | 2000 |
[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
Topics: Acetamides; Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Isoniazid; Linezolid; Mycobacterium bovis; Oxazolidinones; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Antibiotic susceptibility of the bacteria causing odontogenic infections.
Topics: Acetamides; Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Clindamycin; Drug Resistance, Bacterial; Female; Focal Infection, Dental; Humans; Linezolid; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Molar, Third; Oxazolidinones; Periapical Periodontitis; Pericoronitis; Tetracycline | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Simultaneous determination and validation of antimicrobials in plasma and tissue of actinomycetoma by high-performance liquid chromatography with diode array and fluorescence detection.
Topics: Acetamides; Acetonitriles; Amoxicillin; Animals; Anti-Bacterial Agents; Buffers; Chemical Precipitation; Chromatography, High Pressure Liquid; Drug Stability; Fluoroquinolones; Freezing; Hydrogen-Ion Concentration; Linezolid; Mice; Mycetoma; Oxazolidinones; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfamethoxazole; Time Factors; Trimethoprim; Water | 2007 |
[Two cases of pulmonary gangrene in HIV-infected patients: favorable outcome without surgery].
Topics: Acetamides; Adult; Alcoholism; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gangrene; Gentamicins; HIV Infections; Humans; Imipenem; Linezolid; Lung; Male; Metronidazole; Necrosis; Ofloxacin; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Smoking; Tomography, X-Ray Computed | 2011 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
Development of novel molecularly imprinted solid-phase microextraction fibers and their application for the determination of antibiotic drugs in biological samples by SPME-LC/MS(n).
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Daptomycin; Humans; Linezolid; Mass Spectrometry; Molecular Imprinting; Oxazolidinones; Polymers; Pyrroles; Sensitivity and Specificity; Solid Phase Microextraction; Thiophenes | 2012 |
A new approach for antibiotic drugs determination in human plasma by liquid chromatography-mass spectrometry.
Topics: Acetamides; Aged; Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Fluoroquinolones; Gemifloxacin; Humans; Linezolid; Mass Spectrometry; Middle Aged; Naphthyridines; Oxazolidinones; Reproducibility of Results; Solid Phase Microextraction | 2013 |
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Stents; Urinary Tract; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2013 |
Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Linezolid; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2015 |
A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Combined Modality Therapy; Drug Combinations; Drug Synergism; Light; Linezolid; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phototherapy; Silver; Vancomycin | 2016 |
Synergistic Effects of Thiosemicarbazides with Clinical Drugs against
Topics: Amoxicillin; Anti-Bacterial Agents; Cell Line; Cell Survival; DNA Gyrase; DNA Topoisomerase IV; Drug Combinations; Drug Synergism; Fibroblasts; Gene Expression; Gentamicins; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Semicarbazides; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2020 |
CE-DAD-MS/MS in the simultaneous determination and identification of selected antibiotic drugs and their metabolites in human urine samples.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Clindamycin; Electrophoresis, Capillary; Humans; Linezolid; Metronidazole; Tandem Mass Spectrometry | 2022 |
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Ifosfamide; Imipenem; Linezolid; Microbial Sensitivity Tests; Mycetoma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy.
Topics: Amoxicillin; Anti-Bacterial Agents; Dicloxacillin; Endocarditis; Endocarditis, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Rifampin | 2023 |
Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Drug Resistance, Bacterial; Globus Pallidus; Humans; Infant, Newborn; Linezolid; Macrolides; Syphilis; Treponema; Treponema pallidum | 2023 |